Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4: Can Patient-derived Cancer Models Change the Costliest Cancer Type?

: Kimmo Kettunen, Peter Boström, Pekka Taimen

Publisher: ELSEVIER

: 2020

: European Urology

: EUROPEAN UROLOGY

: EUR UROL

: 77

: 1

: E23

: E23

: 1

: 0302-2838

: 1873-7560

DOI: https://doi.org/10.1016/j.eururo.2019.09.011